Onmanorama Lite App
Wednesday, Aug 13, 2025
Research has shown that viral respiratory infections such as seasonal influenza and COVID-19 are risk factors for cardiovascular disease.
A UK university said that it is leading the UK arm of the worldwide research called the BCG vaccination to Reduce the impact of COVID-19 in healthcare workers trial.
The study, published in a journal demonstrated that the new technique can correctly identify positive COVID-19 cases 84 per cent of the time.
For the study, the researchers analysed data from two groups of older people aged 65 or over from March through May.
Russia became the first country to give regulatory approval to a Covid-19 vaccine in August when Sputnik V was officially registered ahead of large-scale clinical trial.
The study found that a vaccine capable of eliciting a strong immune response could substantially reduce future caseloads.
Covishield is a vaccine developed by AstraZeneca and Oxford and will be manufactured by SII.
The surveillance system can dynamically track not just where the virus is now, but where it is going, how fast it will arrive and whether that speed is accelerating and so on.
While studies have suggested that those with type 2 diabetes are at higher risk if they get COVID-19, little is known about the risk for individuals with type 1 diabetes.
Massachusetts-based biotechnology giant Moderna has commenced stage 2 trials for its new coronavirus vaccine and aims to enrol 600 participants.
Results 281-290 of 327
You can always sign back in at any time.
You have reached the maximum number of saved items. Please remove some items.
